Alpa Labs Q1 FY27: Revenue up 25% YoY, PAT drops sharply

Revenue Growth 20pctResults View source PDF Explain this filing

ALPA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-2.4%Reaction day

₹65.90

prior close

₹65.85

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.1%-2.5% vs market

Pharmaceuticals peers, median of 166sector-0.4%-2.0% vs sector

On the reaction day the stock moved 2.5 pts less than Nifty Microcap 250 and 2.0 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+1.7

10m

+0.2

15m

+0.1

30m

-1.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-2.4+0.1-2.5-0.4-2.0

Next day

-3.4+0.2-3.6-0.3-3.1

-3.9+0.6-4.5-0.5-3.4

-7.1-0.0-7.1-1.3-5.8

-4.8+0.5-5.3-0.8-4.0

-4.1+0.8-4.9-0.4-3.7

-5.4+0.6-6.0-0.9-4.5

15d

-4.4+1.3-5.7+0.0-4.5

-7.4-1.4-6.1-0.1-7.3

-12.9-0.6-12.3-2.6-10.3

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 166Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Alpa Labs posted Q1 FY27 standalone revenue from operations of Rs 2,393.05 lakhs, up 25% from Rs 1,911.07 lakhs in Q1 FY26. However, PAT fell sharply to Rs 103.84 lakhs from Rs 1,177.59 lakhs, as other income dropped to Rs 582.93 lakhs from Rs 1,195.78 lakhs (prior year had large unrealized investment gains). Standalone EPS at Rs 0.52 vs Rs 5.60. Total expenses rose to Rs 2,872.14 lakhs from Rs 1,929.26 lakhs. Auditor gave an unmodified review report. Board also approved 38th AGM notice.

Likely market impact

Strong topline growth is positive, but sharp PAT decline driven by lower investment gains may weigh on the stock; focus shifts to operating margins.